TAF + Emtricitabine + Elvitegravir + Cobicistat Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TAF – 10 mg
Reference Brands: Genvoya(US & EU)
Category: Anti Viral
Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide (150/150/200/10 mg) single-tablet HIV-1 regimen. For importers, distributors, HIV clinics and hospital pharmacies sourcing a once-daily integrase-based combination.
Manufacture or export TAF + Emtricitabine + Elvitegravir + Cobicistat? List it or send an offer →
Product Description:
This fixed-dose tablet combines four antiretrovirals into one complete daily regimen for HIV-1. Elvitegravir 150 mg is an integrase strand transfer inhibitor that stops viral DNA joining the host genome. Cobicistat 150 mg has no antiviral activity; it inhibits CYP3A and keeps elvitegravir levels high enough for once-daily dosing. Emtricitabine 200 mg and tenofovir alafenamide 10 mg form the nucleoside backbone. Tenofovir alafenamide delivers tenofovir into cells at a much lower dose than the older disoproxil salt, so blood levels of tenofovir are lower.
The tablet is used in adults and in children above a label-defined minimum weight, to start treatment or to switch while virologically suppressed, where no resistance to the components is known. It is taken once a day with food. Cobicistat drives many interactions: rifampicin and St John's wort are contraindicated, and many statins and sedatives need checking. Antacids and mineral supplements are separated from the dose. Cobicistat raises serum creatinine slightly without changing true kidney function. It is not recommended in pregnancy.
Sourcing notes. This combination is prescription-only and registered nationally. WHO guidelines favour dolutegravir-based regimens for most programmes, so demand comes mainly from markets following US or European guidance. Confirm patent and data exclusivity status before planning a generic registration, and check for bioequivalence on all four components. Tablets come in HDPE bottles with a desiccant and must stay in the original container. Request the batch CoA, the GMP certificate, a CoPP and zone IVb stability data. State tablets per bottle and label languages.
TAF + Emtricitabine + Elvitegravir + Cobicistat — third party manufacturing & bulk supply
TAF + Emtricitabine + Elvitegravir + Cobicistat is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
TAF + Emtricitabine + Elvitegravir + Cobicistat is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of TAF + Emtricitabine + Elvitegravir + Cobicistat listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for TAF + Emtricitabine + Elvitegravir + Cob... →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat is used for the treatment of HIV-1 infection. It works as a complete once-daily regimen that suppresses viral replication and helps maintain long-term viral suppression.
It is made from the active ingredients tenofovir alafenamide (TAF), emtricitabine, elvitegravir, and cobicistat. TAF and emtricitabine are nucleoside reverse transcriptase inhibitors, elvitegravir is an integrase inhibitor, and cobicistat is a pharmacokinetic enhancer that boosts elvitegravir levels.
The main trade name is Genvoya in the USA, EU, and UK.
Genvoya is manufactured by Gilead Sciences.
The generic name is tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat.
The primary brand name is Genvoya.
It is manufactured by Gilead Sciences in the USA and EU, along with authorized global manufacturing partners.
Related Products
Tenofovir AF + Emtricitabine
Strength:
Tenofovir AF 25 mg + Emtricitabine 200 mg
Form: Tablet
Reference Brands: Descovy(EU & US)
View DetailsTAF + Emtricitabine + Rilpivirine
Strength:
(TAF) – 25 mg + Emtricitabine – 200 mg + Rilpivirine – 25 mg
Form: Tablet
Reference Brands: Odefsey(US & EU)
View DetailsTenofovir DF + Emtricitabine + Elvitegravir + Cobicistat
Strength:
Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TDF – 300 mg
Form: Oral tablet (film-coated)
Reference Brands: Stribild (US & EU)
View DetailsTenofovir AF + Emtricitabine + Bictegravir
Strength:
Bictegravir-50 mg + Emtricitabine-200 mg + TAF-25 mg
Form: Tablet
Reference Brands: Biktarvy(EU & US)
View DetailsEtravirine
Strength:
25 mg, 100 mg, 200 mg
Form: Tablets
Reference Brands: Intelence (USA), Intelence (EU)
View DetailsEnfuvirtide Acetate
Strength:
90 mg/vial
Form: Injection
Reference Brands: Fuzeon (USA/EU)
View DetailsRaltegravir
Strength:
100mg, 400 mg, 600mg
Form: Tablets
Reference Brands: Isentress (USA/EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit